Literature DB >> 18324891

Plasmodium falciparum malaria vaccines in development.

Johan Vekemans1, W Ripley Ballou.   

Abstract

The development and implementation of a malaria vaccine would constitute a major breakthrough for global health. Recently, numerous new candidates have entered clinical testing, following strategies that are as diverse as the malaria cycle is complex. While promising results have been obtained, some candidate vaccines have not fulfilled expectations. The challenges are not merely scientific; further progresses will require the development of competent investigator networks, partnerships between academics, industry and funding agencies, and continuous political commitment. In this review, we present the developmental status of all malaria vaccine candidates that are currently in human clinical testing against Plasmodium falciparum, as well as selected malaria vaccine candidates at preclinical development stage, and discuss the main challenges facing the field of malaria vaccine development.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18324891     DOI: 10.1586/14760584.7.2.223

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN: 1476-0584            Impact factor:   5.217


  34 in total

1.  Evaluation of three medicinal plant extracts against Plasmodium falciparum and selected microganisms.

Authors:  Abiodun Falodun; Vincent Imieje; Osayewenre Erharuyi; Joy Ahomafor; Melissa R Jacob; Shabana I Khan; Mark T Hamann
Journal:  Afr J Tradit Complement Altern Med       Date:  2014-06-04

2.  Anti-apical-membrane-antigen-1 antibody is more effective than anti-42-kilodalton-merozoite-surface-protein-1 antibody in inhibiting plasmodium falciparum growth, as determined by the in vitro growth inhibition assay.

Authors:  Kazutoyo Miura; Hong Zhou; Ababacar Diouf; Samuel E Moretz; Michael P Fay; Louis H Miller; Laura B Martin; Mark A Pierce; Ruth D Ellis; Gregory E D Mullen; Carole A Long
Journal:  Clin Vaccine Immunol       Date:  2009-05-13

3.  In vitro evaluation of aliphatic fatty alcohol metabolites of Perseaamericana seed as potential antimalarial and antimicrobial agents.

Authors:  A Falodun; O Erharuyi; V Imieje; J Ahomafor; C Akunyuli; M Jacobs; S Khan; M T Hamann; P Langer
Journal:  Niger J Biotechnol       Date:  2014

4.  A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarray.

Authors:  Peter D Crompton; Matthew A Kayala; Boubacar Traore; Kassoum Kayentao; Aissata Ongoiba; Greta E Weiss; Douglas M Molina; Chad R Burk; Michael Waisberg; Algis Jasinskas; Xiaolin Tan; Safiatou Doumbo; Didier Doumtabe; Younoussou Kone; David L Narum; Xiaowu Liang; Ogobara K Doumbo; Louis H Miller; Denise L Doolan; Pierre Baldi; Philip L Felgner; Susan K Pierce
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-29       Impact factor: 11.205

5.  Solution conformation, backbone dynamics and lipid interactions of the intrinsically unstructured malaria surface protein MSP2.

Authors:  Xuecheng Zhang; Matthew A Perugini; Shenggen Yao; Christopher G Adda; Vincent J Murphy; Andrew Low; Robin F Anders; Raymond S Norton
Journal:  J Mol Biol       Date:  2008-03-28       Impact factor: 5.469

6.  Meta-analysis of immune epitope data for all Plasmodia: overview and applications for malarial immunobiology and vaccine-related issues.

Authors:  K Vaughan; M Blythe; J Greenbaum; Q Zhang; B Peters; D L Doolan; A Sette
Journal:  Parasite Immunol       Date:  2009-02       Impact factor: 2.280

7.  The Plasmodium falciparum-specific human memory B cell compartment expands gradually with repeated malaria infections.

Authors:  Greta E Weiss; Boubacar Traore; Kassoum Kayentao; Aissata Ongoiba; Safiatou Doumbo; Didier Doumtabe; Younoussou Kone; Seydou Dia; Agnes Guindo; Abdramane Traore; Chiung-Yu Huang; Kazutoyo Miura; Marko Mircetic; Shanping Li; Amy Baughman; David L Narum; Louis H Miller; Ogobara K Doumbo; Susan K Pierce; Peter D Crompton
Journal:  PLoS Pathog       Date:  2010-05-20       Impact factor: 6.823

Review 8.  How might infant and paediatric immune responses influence malaria vaccine efficacy?

Authors:  A M Moormann
Journal:  Parasite Immunol       Date:  2009-09       Impact factor: 2.280

9.  Population diversity and antibody selective pressure to Plasmodium falciparum MSP1 block2 locus in an African malaria-endemic setting.

Authors:  Nitchakarn Noranate; Franck Prugnolle; Hélène Jouin; Adama Tall; Laurence Marrama; Cheikh Sokhna; Marie-Thérèse Ekala; Micheline Guillotte; Emmanuel Bischoff; Christiane Bouchier; Jintana Patarapotikul; Jun Ohashi; Jean-François Trape; Christophe Rogier; Odile Mercereau-Puijalon
Journal:  BMC Microbiol       Date:  2009-10-15       Impact factor: 3.605

10.  A potent malaria transmission blocking vaccine based on codon harmonized full length Pfs48/45 expressed in Escherichia coli.

Authors:  Debabani Roy Chowdhury; Evelina Angov; Thomas Kariuki; Nirbhay Kumar
Journal:  PLoS One       Date:  2009-07-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.